Fazli R. Awan Characterization of a Mouse Model of Sandhoff Disease by Magnetic Resonance Methods Supervisors Dr Fran M Platt Prof Peter Styles.

Slides:



Advertisements
Similar presentations
Neuro-Imaging High Resolution Ex-Vivo MRI Ex-Vivo DTI of Brain Stem
Advertisements

Imaging Methods: Gait, Cognition and Mood Richard Camicioli MD University of Alberta Edmonton, Alberta
Introduction to MRI Magnetic Resonance Imaging
MRI Phillip W Patton, Ph.D..
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
The importance of MRI, a few numbers  MRI units worldwide in 2003  75 millions scans per year performed  Constant need for over 1000 MRI technologists.
Polymicrogyria Natalie Crawford Karen Inzana D. Phillip Sponenberg Virginia – Maryland Regional College of Veterinary Medicine Blacksburg, Virginia Presented.
A SADDLE QUADRATURE RF COIL for IN VIVO RODENT IMAGING at 21.1 T Jose A. Muniz 1,2, Jens T. Rosenberg 1,2 & S.C. Grant 1,2 1 The National High Magnetic.
The Dependence of the Apparent Diffusion Coefficient on Voxel Location and Calculation Method Lars Ewell 1, Naren Vijayakumar Meeting of the American.
Electrical eddy currents in the human body: MRI scans and medical implants Brent Hoffmeister Rhodes College Department of Physics.
fMRI introduction Michael Firbank
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Method for Determining Apparent Diffusion Coefficient Values for Cerebral Lesions from Diffusion Weighted Magnetic Resonance Imaging Examinations T.H.
Desiree Abdurrachim Morphometric analysis of the hippocampus in R6/1 HD mouse model Internship August – October 2007 Desiree Abdurrachim Supervisor: Leigh.
Peripheral Immune System of Glycosphingolipid Storage Disorder Mouse Models Aruna Jeans.
Team Members: Team Leader- Jeremy Glynn Communicator- Jeremy Schaefer BSAC- Mike Conrardy BWIG- Adam Goon Client- Ian Rowland, Ph.D., Department Of Radiology.
Amyotrophic Lateral Sclerosis (ALS) Sarah Belair and Hannah McLaughlin.
Gd-DTPA as an MRI Contrast Agent Lindsay Dods April 6, 2010 Supervisors: Robert Ta, Masters Student Robert Bartha, Ph.D.
Developing an in vitro cellular model for Fabry Disease Part II Project Emma Brewer
Glycoconjugate storage & pathogenesis in an in vitro cellular model of Sandhoff disease Stephanie Boomkamp.
Restricted distribution of Isoglobotrihexosylceramide (iGb3) - Implications for natural endogenous NKT cell selecting and activating ligand(s) Annie Speak.
HEXA and Tay-Sachs Disease
M. D. A NDERSON Cancer Center Magnetic Resonance Imaging: 4.7 T, 40 cm Bruker Biospec James A Bankson, Ph.D. and John D Hazle, Ph.D. Small Animal Cancer.
Sylwia Heinze-Paluchowska Department of Magnetic Resonance Imaging (NZ56)
Vladislav Toronov, Ph. D. Using Physics to Image Brain Function.
FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.
Functional Spectroscopy of Brain Activation Following a Single light Pulse: Examinations of the Mechanism of the Fast Initial Response. J.Henning,C.Janz,O.Speck,and.
BRAIN ART How and Why We Study the Brain This slide-show was completed with the help of Roberto Gradini MD, PHD, Associate Professor of General Pathology,
Pulse Sequences Types of Pulse Sequences: Functional Techniques
Dr. Jones University of Arkansas.  Disease  Pathology  Etiology.
September, 2003BME 1450 Introduction to NMR 1 Nuclear Magnetic Resonance (NMR) is a phenomenon discovered about 60 years ago.
Fahrenheit, Celsius & Kelvin. Temperature  Is a measure of how hot or cold an object is compared to another object.  Indicates that heat flows from.
Recent SPECT/CT Imaging Studies using ORNL/JLAB instrumentation Bethesda May 20, 2005.
Brain Metabolites in Patients with Asymptomatic Versus Symptomatic HIV-associated neurocognitive disorder: A 7 Tesla MR Spectroscopy Study Mohamed MA,
March 22, 2011 Issac Yang Supervisor: Charles McKenzie, PhD
MRI Physics Dr Mohamed El Safwany, MD.. MRI Magnetic Resonance Imaging Magnetic Resonance Imaging.
An Investigation of Perfusion in Stroke Survivors Kathleen Brumm 1, Thomas Liu 2, Joanna Perthen 2, Frank Haist 2, Tracy Love 1, 2, 3 1 SDSU/ UCSD Joint.
Oregon Health & Science University and Northwest PADRECC
Clinical Assessment of LINCL
University of Western Ontario
Origin of Negative BOLD fMRI Signals
Magnetic Resonance Imaging (MRI). The Components: A magnet which produces a very powerful uniform magnetic field. A magnet which produces a very powerful.
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study Bartzokis, et al. UCLA.
What are we measuring in fMRI?
Magnetic Resonance Imaging Glenn Pierce, King’s College London, Department of Physics Introduction Edward Purcell and Felix Bloch were both awarded the.
Pathogenesis and pathology of parkinsonism
Diffusion Magnetic Resonance Imaging (dMRI) Meysam Golmohammadi.
MRI Magnetic Resonance Imaging. Definition A non-ionizing technique with full three dimensional capabilities, excellent soft-tissue contrast, and high.
BY: GRACE STOUT. What is Alzheimer’s and what does it do to the human body?  Alzheimer’s Disease is a progressive, neurodegenerative disorder that is.
Lyme disease is a Bacterial Infection Dr. Peter Dobie.
Understanding the Brain The Brain Song. Electroencephalograph (EEG) Monitors the electrical activity of the brain- brain waves Used in clinical diagnosis.
BOLD functional MRI Magnetic properties of oxyhemoglobin and deoxyhemoglobin L. Pauling and C. Coryell, PNAS USA 22: (1936) BOLD effects in vivo.
M-SeriesTM Compact MRI Systems
Erin Chown APBDRF Scientific Advisory Board Meeting
Hai-Yu Wang, Ye-Yu Xiao, Ren-Hua Wu Department of Medical Imaging
How MRI Works Connor Schentag.
DIFFUSION ABNORMALITY OF CORPUS CALLOSUM IN ALZHEIMER’S DISEASE
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Review of Literature Zebin Xiao Department of.
Neuro-imaging applications in Psychiatry
Measurement of Capillary Recruitment
A 74-year old woman with progressive amnesia
Figure 1 Cerebral MRI during the disease course Cerebral MRI with multiple cerebral supratentorial lesions during the disease course: periventricular lesions.
NEUROIMAGING FINDINGS OF RARE NEURODEGENERATIVE DISEASES RELATED TO DEMENTIA SYMPTOMS INTRODUCTION: Neurodegenerative diseases are diversified group of.
Clinical Assessment David H. Barlow V. Mark Durand Chapter 3 p
Functional Neuroimaging: a window on the working human brain
Brain MR imaging on DOL 2 in patient 5 while he was treated with induced hypothermia; comparison between the perfusion map and images obtained from conventional.
Single-site disease progression after 9 months of response to therapy in the right hemipelvis visualized by diffusion-weighted whole-body MRI. Top, fusion.
MIP of a 7T susceptibility-weighted image of the brain of a healthy volunteer revealing tiny venules in the cortex. MIP of a 7T susceptibility-weighted.
Presentation transcript:

Fazli R. Awan Characterization of a Mouse Model of Sandhoff Disease by Magnetic Resonance Methods Supervisors Dr Fran M Platt Prof Peter Styles

Sandhoff Disease A type of Glycolipid (i.e. Glycosphinoglipid) lysosomal storage disorder Defect in the  -gene of the enzyme  - Hexosaminidase A (  ) and B (  ) A neurodegenerative disease Knockout mouse model for Sandhoff disease

Head tremor Muscle weakness Ataxic gait Motor dysfunction Hind limb paralysis Immobile unresponsive state Humane end point Natural death Age in Weeks Disease Progression in Sandhoff Mice 2-Month3-Month4-Month

What mouse models could tell us about the diseases? Much about the biochemistry, pathology and clinical course of the disease BY……. Various biochemical and immunohistology methods In Vitro or Ex Vivo (a main limitation) BUT ?

To find out disease related changes in Sandhoff mice by in vivo MR methods Aim

400 MHz Vertical Bore Magnet Mouse head Mouse here Anaesthesia and Scavenging tubes Portion of the Probe showing coil region

Anaesthesia RF cable Data acquisition Magnet RF coil Heating blanket Water pipe Body temperature Heart rate / ECG Mouse

IMAGING PROTOCOL

MRI Scans Brain water diffusion studies by ADC mapping T2 and T1 Relaxation Times Magnetization Transfer Ratios (MTRs) Cerebral blood flow (CBF) by ASSIST-MRI

MRI Data Analysis In whole brain HorizontalSagittal

MRI Data Analysis In specific regions

STUDY DESIGN (Disease stages studied in Sandhoff mice) Presymptomatic (2 month) Early symptomatic (3 month) Terminal stage (4 month)

Apparent Diffusion Coefficient (ADC) Decreases in Sandhoff Mice * Whole-brain 8% ↓ Diffusion of water in Sandhoff mouse brain is low

Sandhoff Control Bins on x-axis in all of the above histograms represent ADC (10 -5 mm 2 /sec) ADC Histograms for 4-Month-Old Mice

* Decrease in ADC in the cerebral cortex of Sandhoff mouse brain ADC Analysis in Specific Regions of Sandhoff Mouse Brain Water diffusion in Sandhoff mice was low at all the three ages, in almost all of the brain regions investigated. 11% ↓

T2 (Spin-Spin) Relaxation Time (Reduced in Sandhoff Mouse Brain ! ) ** In whole-brain 8% ↓

Histograms for T2 Relaxation Time in 4-Month-Old Mice Sandhoff Control Bins on x-axis in all of the above histograms represent T 2 relaxation time (msec)

T2 Relaxation Time Decreases with disease progression * ** (A) (B) T2 relaxation time: Increases in controls from 2- 4 month Decrease from 2-4 month in Sandhoff mice

T1 (Spin-lattice) Relaxation Time (Decreases in Sandhoff Mouse Brain ! ) * * ** 4-month-old Sandhoff and control mice

Magnetization Transfer Ratios (MTRs) (in Sandhoff and Control Mouse Brain) Lower MTRs in 3 month Sandhoff mice Higher MTRs in 4 month Sandhoff mice BUT NOT SIGNIFICANTLY

Cerebral Blood Flow (CBF) (Measured by ASSIST-MRI) * * CBF increases in Sandhoff mice with disease progression

* * Cerebral Blood Flow (CBF) (comparison of 4-month-old mice)

Summary ADC (water diffusion in the brain) reduces in Sandhoff mice as compared to their age-matched controls T2 relaxation time decreases in Sandhoff mice with the progression of disease T1 relaxation time is short in Sandhoff mice as compared to their age-matched controls. No significant differences in the magnetization transfer ratios (MTRs) between control and Sandhoff mice. Significant increase in the cerebral blood flow (CBF) in the terminal stage Sandhoff mice as compared to controls. This increase in the CBF appears to progress with the disease

Conclusions This is the first time MRI study of Sandhoff mouse brain, and only limited data is available from clinical studies. These findings may have applications for disease diagnosis and therapy monitoring by non-invasive MRI methods.

Acknowledgements Members of 1 st. Floor Mr David Smith Dr M. Jeyakumar Dr David Neville Dr Terry Butters Prof Raymond Dwek Dr Fran PlattProf Peter Styles Members of ENG Dr Niki Sibson Dr Kerry Broom Dr John Lowe Dr AM Blamire Dr Justin Smith Mr Andre Thomas Mr Phillip Bradford (Members of BSU) Experimental Neuroimaging Group (ENG), University Lab. of Physiology